ArticleWorld journal of hepatology2024

Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept.

Mohamed WishahiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.